PRMA Consulting Offers Insight Into US Drug Market and ICER Recommendations

March 18, 2021

PRMA Consulting has released an eBook detailing the major issues faced by pharmaceutical companies in the United States. Access to patients, reimbursement from payers, and navigating ICER recommendations all pose unique challenges. The guide also provides insight into prescription drug policy and discusses the evolving role of technology throughout the drug development pipeline.

“Here’s the good news: market access success doesn’t have to stretch your budgets or create more work. A great place to reinvigorate your thinking is this collection of landmark studies on the US payer landscape and the evolution of ICER’s influence.” Download the free eBook here.